Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP736078.RA25WG82KCCL7_am-ekEsbas-vmAnHMZn574Ov1QxCLFM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP736078.RA25WG82KCCL7_am-ekEsbas-vmAnHMZn574Ov1QxCLFM130_assertion type Assertion NP736078.RA25WG82KCCL7_am-ekEsbas-vmAnHMZn574Ov1QxCLFM130_head.
- NP736078.RA25WG82KCCL7_am-ekEsbas-vmAnHMZn574Ov1QxCLFM130_assertion description "[It was 12% (3/25) in systemic lupus erythematosus, 9.5% (2/21) in primary Sj�gren's syndrome, 10% (1/10) in systemic sclerosis, 20% (2/10) in ankylosing spondylitis, 12.5% (1/8) in viral hepatitis type B, and 0% (0/2) in tuberculosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP736078.RA25WG82KCCL7_am-ekEsbas-vmAnHMZn574Ov1QxCLFM130_provenance.
- NP736078.RA25WG82KCCL7_am-ekEsbas-vmAnHMZn574Ov1QxCLFM130_assertion evidence source_evidence_literature NP736078.RA25WG82KCCL7_am-ekEsbas-vmAnHMZn574Ov1QxCLFM130_provenance.
- NP736078.RA25WG82KCCL7_am-ekEsbas-vmAnHMZn574Ov1QxCLFM130_assertion SIO_000772 19447936 NP736078.RA25WG82KCCL7_am-ekEsbas-vmAnHMZn574Ov1QxCLFM130_provenance.
- NP736078.RA25WG82KCCL7_am-ekEsbas-vmAnHMZn574Ov1QxCLFM130_assertion wasDerivedFrom befree-20140225 NP736078.RA25WG82KCCL7_am-ekEsbas-vmAnHMZn574Ov1QxCLFM130_provenance.
- NP736078.RA25WG82KCCL7_am-ekEsbas-vmAnHMZn574Ov1QxCLFM130_assertion wasGeneratedBy ECO_0000203 NP736078.RA25WG82KCCL7_am-ekEsbas-vmAnHMZn574Ov1QxCLFM130_provenance.